Lyra Therapeutics
LYRA
LYRA
26 hedge funds and large institutions have $20.2M invested in Lyra Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$221K | |
| 2 | +$112K | |
| 3 | +$27.6K | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$13.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.81K |
Top Sellers
| 1 | -$162K | |
| 2 | -$147K | |
| 3 | -$138K | |
| 4 |
Two Sigma Investments
New York
|
-$77K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$58K |